Neuroprotective Effect of Caffeine in Alzheimer’s Disease

Alzheimer’s disease (AD) is the leading cause of dementia, predicted to be the most significant health burden of the 21st century, with an estimated 131.5 million dementia patients by the year 2050. This review aims to provide an overview of the effect of caffeine on AD and cognition by summarizing...

Descripción completa

Detalles Bibliográficos
Autores principales: M Yelanchezian, Y Mukish, Waldvogel, Henry J., Faull, Richard L. M., Kwakowsky, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227174/
https://www.ncbi.nlm.nih.gov/pubmed/35744865
http://dx.doi.org/10.3390/molecules27123737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227174/
https://www.ncbi.nlm.nih.gov/pubmed/35744865
http://dx.doi.org/10.3390/molecules27123737

Ejemplares similares